We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$2.85B
AUM Growth
-$217M
Cap. Flow
-$195M
Cap. Flow %
-6.86%
Top 10 Hldgs %
23.08%
Holding
167
New
5
Increased
16
Reduced
42
Closed
10

Top Buys

Rank Stock Value
1
VSM
Versum Materials, Inc.
VSM
+$2.8M
2
ADNT icon
Adient
ADNT
+$2.22M
3
NXPI icon
NXP Semiconductors
NXPI
+$727K
4
NKE icon
Nike
NKE
+$718K
5
UL icon
Unilever
UL
+$621K

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$28.6M
2
ADBE icon
Adobe
ADBE
+$22.1M
3
NVS icon
Novartis
NVS
+$19.9M
4
INTU icon
Intuit
INTU
+$18.4M
5
AAPL icon
Apple
AAPL
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Industrials 23.12%
3 Healthcare 19.72%
4 Consumer Staples 15.01%
5 Consumer Discretionary 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDS.A
151
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$219K 0.01%
4,034
+19
+0.5% +$979
OVV icon
152
Ovintiv
OVV
$17.5B
$167K 0.01%
2,840
+200
+8% +$11.4K
ORAN
153
DELISTED
Orange
ORAN
$162K 0.01%
10,672
– –
CDE icon
154
Coeur Mining
CDE
$15.6B
$127K ﹤0.01%
14,000
– –
LTM
155
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$109K ﹤0.01%
13,384
– –
ENIA
156
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$82K ﹤0.01%
10,000
– –
ULBI icon
157
Ultralife
ULBI
$88.3M
$50K ﹤0.01%
10,000
– –
ABEV icon
158
Ambev
ABEV
$47.3B
– –
-15,000
Closed -$91K
BIIB icon
159
Biogen
BIIB
$29.9B
– –
-941
Closed -$295K
CVE icon
160
Cenovus Energy
CVE
$54.6B
– –
-21,600
Closed -$310K
DHC
161
Diversified Healthcare Trust
DHC
$2.26B
– –
-9,800
Closed -$223K
INFY icon
162
Infosys
INFY
$45B
– –
-800,000
Closed -$6.31M
SRE icon
163
Sempra
SRE
$60.8B
– –
-4,280
Closed -$229K
ESRX
164
DELISTED
Express Scripts Holding Company
ESRX
– –
-405,532
Closed -$28.6M
3 4 5 6
7

Similar funds

FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $7.06B AUM 28.93% 1-Year Est. Return

Saturna Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Saturna Capital held 167 positions worth $2.85B, down 7.1% from $3.06B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Saturna Capital withdrew a net $195M in Q4 2016, closing 10 positions and reducing 42 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Saturna Capital opened a new position in Versum Materials, Inc. worth $3.16M.

  • Saturna Capital's largest Q4 2016 buy was Versum Materials, Inc.: 112,500 shares worth $3.16M.
  • Saturna Capital added most to Nike in Q4 2016, an estimated $718K increase.
  • Saturna Capital's biggest Q4 2016 reduction was Adobe, cutting an estimated $22.1M.
  • Saturna Capital fully exited Express Scripts Holding Company in Q4 2016, selling an estimated $28.6M.
  • Saturna Capital's ten largest holdings make up 23% of its $2.85B portfolio in Q4 2016.
  • Saturna Capital opened 5 new positions and closed 10 in Q4 2016.
  • Saturna Capital's portfolio value fell 7.1% quarter-over-quarter to $2.85B.

Based on Saturna Capital's 13F filing for Q4 2016, filed 14 Feb 2017.